A carregar...
Non-cardiac benefits of human recombinant erythropoietin in end stage renal failure and anaemia.
Recombinant human erythropoietin (r-HuEpo) is now available to correct the anaemia of end stage renal failure. The clinical consequences of increasing the haemoglobin concentration in children on dialysis are incompletely documented; a placebo controlled study is essential when assessing subjective...
Na minha lista:
| Publicado no: | Arch Dis Child |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMJ Publishing Group
1993
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC1029623/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8257180/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/adc.69.5.580 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|